Showing 5791-5800 of 6035 results for "".
- EyeCare Partners Acquires Holcomb Laser Centerhttps://modernod.com/news/eyecare-partners-acquires-holcomb-laser-center/2479632/EyeCare Partners (ECP) furthered its expansion into the Alabama ophthalmology market with the acquisition of Dr. William Holcomb’s Cullman, Alabama-based Holcomb Laser Center, according to an announcement from EyeCare Partners, as reported in VisionMonday. Terms of the deal were not disclo
- Dry Eye Symptom Screens Show Modest Accuracyhttps://modernod.com/news/dry-eye-symptom-screens-show-modest-accuracy/2479636/In head-to-head comparisons, two of five dry eye screens showed a statistically significant ability to detect signs of the disorder, but all demonstrated relatively modest diagnostic accuracy, researchers say, according to a Reuters report
- Eyenovia Publishes PG21 Phase 2 Trial Results Examining IOP Lowering Effect and Patient Usabilityhttps://modernod.com/news/eyenovia-publishes-pg21-phase-2-trial-results-examining-iop-lowering-effect-and-patient-usability/2479637/Eyenovia announced that the full results of its phase 2 PG21 study have been published in the article “Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose” in the November issue of the peer-
- Lynx Inventory System Now Customized for Retina Specialistshttps://modernod.com/news/lynx-inventory-system-now-customized-for-retina-specialists/2479638/McKesson announced that Lynx, its customizable, cloud-based medication inventory management system for specialty medical practices, has new features designed especially for delivering injectable medication therapies in retina practices. These customizations for retina specialists ensure that each
- Glaucoma-Staging Systems May Underestimate Severityhttps://modernod.com/news/glaucoma-staging-systems-may-underestimate-severity/2479639/Standard automated perimetry (SAP) testing is often used to classify glaucoma severity but may fail to detect macular damage, according to New York City-based researchers, as reported in Reuters. “Because current staging syst
- Genentech Acquires Jecure Therapeuticshttps://modernod.com/news/genentech-acquires-jecure-therapeutics/2479641/Jecure Therapeutics, a biotechnology company with drug discovery programs targeting serious inflammatory diseases, announced a definitive agreement by which it will be acquired by Genentech, the maker of Lucentis (ranibizumab). Terms of the deal were not disclosed. With this acquis
- EyePoint Pharmaceuticals Appoints Ron Honig, Esq., as SVP, General Counsel & Company Secretaryhttps://modernod.com/news/eyepoint-pharmaceuticals-appoints-ron-honig-esq-as-svp-general-counsel-company-secretary/2479642/EyePoint Pharmaceuticals announced the appointment of Ron Honig, Esq., as Senior Vice President, general counsel, and company secretary, effective immediately. In this new role, Mr. Honig will the oversee the company’s legal activities, including the legal aspects of licensing, compliance, strate
- SECO 2019 Puts Spotlight On Vision Industry Trendshttps://modernod.com/news/seco-2019-puts-spotlight-on-vision-industry-trends/2479643/SECO 2019 will lead the conversation on the latest vision industry trends when SECO 2019 takes place February 20-24, 2019 in New Orleans. From the latest technological innovations in eye and healthcare to up-and-coming eyewear products, SECO 2019 is where the optometric community of professional
- Interface Biologics Completes Pre-IND Meeting with FDA on Epidel Technology for Treatment of Posterior Inflammatory Eye Diseaseshttps://modernod.com/news/interface-biologics-completes-pre-ind-meeting-with-fda-on-epidel-technology-for-treatment-of-posterior-inflammatory-eye-diseases/2479645/Interface Biologics has announced a positive pre-investigational new drug meeting with the FDA for its dexamethasone intravitreal implant for the treatment of posterior inflammatory eye diseases. The FDA concurred with IBI’s manufacturing and clinical development plans, based on the precl
- Warby Parker Eyewear Now Available to People Enrolled in UnitedHealthcare Medicare Advantage Planshttps://modernod.com/news/warby-parker-eyewear-now-available-to-people-enrolled-in-unitedhealthcare-medicare-advantage-plans/2479652/For the first time, Warby Parker is accepting Medicare insurance. The company’s designer prescription eyewear is available to approximately 2 million people enrolled in UnitedHealthcare Medicare Advantage plans, either online or at more than 80 Warby Parker stores nationwide, according to a